NEW YORK (Reuters Health) – Pegylated liposomal doxorubicin may be an alternative to paclitaxel in combination with carboplatin for advanced ovarian cancer, based on the results of an…
NEW YORK (Reuters Health) – For removal of uterine contents during the second trimester, dilation and evacuation (D&E) appears to prompt fewer complications and may be more cost-effective…
NEW YORK (Reuters Health) – In pregnant women colonized with group B streptococcus (GBS) and at high risk for penicillin anaphylaxis, intrapartum prophylaxis with clindamycin to prevent perinatal…
NEW YORK (Reuters Health) – A new report concludes that expectant management of severe preeclampsia occurring before 34 weeks gestation is appropriate in selected cases. It can prolong…
NEW YORK (Reuters Health) – For women giving birth, a high-dose oxytocin regimen results in a shorter duration of labor without increasing the c-section rate or adversely affecting…
NEW YORK (Reuters Health) – In young women with breast cancer, temporary ovarian suppression by the gonadotropin-releasing hormone analogue triptorelin during chemotherapy reduces the occurrence of premature menopause,…
NEW YORK (Reuters Health) – Frenotomy in newborns with significant ankyloglossia rapidly improves breastfeeding scores and reduces maternal nipple pain, according to the results of a randomized trial…
NEW YORK (Reuters Health) – When used as adjuvant therapy in high-risk breast cancer or as primary treatment for metastatic breast cancer, high-dose chemotherapy (HDC) with autologous stem-cell…
NEW YORK (Reuters Health) – The levonorgestrel-releasing intrauterine system (LNG-IUS) is as effective as systemic progestogen regimens for endometrial protection in women taking estrogen replacement therapy for menopausal…
NEW YORK (Reuters Health) – Women with a history of an atrial switch procedure for congenital d-transposition of the great arteries are at risk of untoward pregnancy outcomes,…